Thrivent Financial for Lutherans’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$147M Buy
1,433,503
+120,959
+9% +$7.87M 0.25% 81
2026
Q1
$62.4M Sell
1,312,544
-48,811
-4% -$2.19M 0.12% 210
2025
Q4
$43.2M Sell
1,361,355
-101,730
-7% -$3.17M 0.08% 298
2025
Q3
$41.2M Buy
1,463,085
+184,726
+14% +$5.59M 0.08% 269
2025
Q2
$47M Sell
1,278,359
-230,778
-15% -$7.97M 0.1% 238
2025
Q1
$59.2M Buy
1,509,137
+3,384
+0.2% +$152K 0.13% 205
2024
Q4
$70M Buy
1,505,753
+532,040
+55% +$24M 0.14% 207
2024
Q3
$44M Buy
+973,713
New +$46.3M 0.08% 299
2023
Q2
Sell
-56,139
Closed -$847K 2544
2023
Q1
$847K Hold
56,139
﹤0.01% 1873
2022
Q4
$1.34M Hold
56,139
﹤0.01% 1541
2022
Q3
$1.98M Buy
+56,139
New +$2.38M 0.01% 1224

Other funds holding TWST

Thrivent Financial for Lutherans's TWST Position: Q2 2026 in Review

Thrivent Financial for Lutherans increased its Twist Bioscience (TWST) stake by 9.2% in Q2 2026, buying an estimated $7.87M and bringing the position to 1,433,503 shares worth $147M. The position accounts for 0.25% of the portfolio, ranked #81.

Thrivent Financial for Lutherans first reported a position in TWST in Q3 2022 and has held it in 11 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Thrivent Financial for Lutherans held 1,433,503 shares of Twist Bioscience worth $147M as of Q2 2026.
  • Thrivent Financial for Lutherans bought 120,959 Twist Bioscience shares in Q2 2026, an estimated $7.87M.
  • Twist Bioscience made up 0.25% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #81 holding.
  • Thrivent Financial for Lutherans first reported a position in Twist Bioscience in Q3 2022 and has held it in 11 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.